Homocysteine increase folate oxidative brain homocysteine metabolism and various consequences of folate deficiency

Journal of Alzheimer's Disease

Volumn 9, Issue 4, 2006, Pages 421-427

  Tchantchou, Flaubert ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Alzheimer's disease; Folic acid; Homocysteine; s adenosylmethione (SAM)

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; AMINO ACID; ANTIOXIDANT; FOLIC ACID; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HOMOCYSTEINE; METHIONINE; METHYL GROUP; S ADENOSYLMETHIONINE; VITAMIN B GROUP;

ALZHEIMER DISEASE; BRAIN METABOLISM; CARDIOVASCULAR DISEASE; CHEMICAL REACTION; FOLIC ACID DEFICIENCY; HUMAN; NEURAL TUBE DEFECT; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SULFURATION; TRANSMETHYLATION;

EID: 33747434129     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9408     Document Type: Review

References (39)

1. J. Selhub, Homocysteine metabolism, Annual Review of Nutrition 19 (1999), 217-246.
2. T.B. Shea and E. Rogers, Homocysteine as a risk factor for Alzheimer's disease, New Eng J Med (20 June 2002), 2002.
3. S. Seshadri, A. Beiser, J. Selhub, P.F. Jacques, H. Rosenberg, R.B. D'Agostino, P.W.F. Wilson and P.A. Wolf, Plasma homocysteine as a risk factor for dementia and Alzheimer's disease, New Engl J Med 346 (2002), 476-483.
4. J.W. Miller, Homocysteine and Alzheimer's disease, Nutr Rev 57 (1999), 126-129.
5. Kruman et al., Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease, J Neurosci 22 (2002), 1752-1762.
6. C.M. Ulrich, K. Robien and R. Sparks, Pharmacogenetics and folate metabolism: a promising direction, Pharmacogenomics 3(3) (2002), 299-313.
7. F. Tchantchou, M. Graves, D. Ortiz, D. Chan, E. Rogers and T.B. Shea, S-adenosyl methionine: a connection between nutritional and genetic risk factors for neurodegeneration in Alzheimer's disease, J Health, Nutrition and Aging, in press.
8. J. Chen, C. Kyte, M. Valcin, W. Chan, J.G. Wetmur, J. Selhub, D.J. Hunter and M.A. Jing, Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study, International Journal of Cancer 110(4) (2004), 617-620.
9. J. Raber, D. Wong, M. Buttini, M. Orth, S. Bellosta, R.E. Pitas, R.W. Mahley and L. Mucke, Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females, Neurobiology Proc Natl Acad Sci USA 95(18) (1998), 10914-10919.
10. L.D. Brotto and Q. Yang, 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review, Am J Epidemiol 151 (2005), 862-867.
11. D.C. Shields et al., The thermolabile variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother, Am J Hum Genet 64 (1999), 1045-1055.
12. A. Bronstrup, M. Hages, R. Prinz-Langenohl and K. Pietrzik, Effects of folic acid and combinations of folic acid and vitamin B12 on plasma homocysteine concentrations in healthy young women, Am J Clin Nutr 68 (1998), 1104-1110.
13. L.I. Al-Gazali et al., Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect, Am J Med Genet 103 (2001), 128-132.
14. P.I. Ho et al., Homocysteine potentiates beta-amyloid neurotoxicity, role of oxidative stress, J Neurochem 78 (2001), 249-253.
15. M.P. Mattson, Haberman, Folate and Homocysteine Metabolism: Therapeutic Targets in Cardiovascular and Neurodegenerative Disorders, Current Medicinal Chemistry 10(19) (2003), 1923-1929.
16. T.B. Shea, J. Lyons-Wieler and E. Rogers, Homocysteine, folate deprivation and Alzheimer neuropathology, J Alz Dis 3 (2001), 1-7.
17. P.I. Ho, D. Ashline, S. Dhitavat, D. Ortiz, S.C. Collins, T.B. Shea and E. Rogers, Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine, Neurobiol Disease 14(10) (2003), 32-42.
18. M.P. Mattson, S.L. Chan and W. Duan, Modification of Brain Aging and Neurodegenerative Disorders by Genes, Diet, and Behavior, Physiol Rev 82 (2002), 637-672.
19. A.L. Miller and G.S. Kelly, Homocysteine Metabolism: Nutritional Modulation and Impact on Health and Disease, Altern Med Rev 2 (1997), 234-254.
20. F. Tchantchou, M. Graves and T.B. Shea, Expression and activity of methionine cycle genes are altered following folate and vitamin E deficiency under oxidative challenge: Modulation by apolipoprotein E-deficiency, Nutritional Neuroscience 9(1-2) (2006), 17-24.
21. E. Mosharov, M.R. Cranford and R. Banerjee, The Quantitatively Important Relationship between Homocysteine Metabolism and Glutathione Synthesis by the Transsulfuration Pathway and Its Regulation by Redox Changes, Biochemistry 39(42) (2000), 13005-13011.
22. M.P. Mattson and T.B. Shea, Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders, Trends in Neurosciences 26(3) (2003), 137-146.
23. J. Selhub and J.W. Miller, The pathogenesis of homocysteinemia, interruption of the coordinate regulation by S-adenosylmethionine of theremethylation and transsulfuration of homocysteine, Am J Clin Nutr 55 (1992), 131-138.
24. G.L. Cantoni, The centrality of S-adenosylhomocysteine in the regulation of the biological utilization of S-adenosylmethionine, in: Biological Methylation and Drug Design, Experimental and Clinical Roles of SAM, C. Borchardt and P.M. Ueland, eds, Humana Press, 1986, pp. 227-237.
25. C. Melanie, Fisher, H. Steven, S.H. Zeisel, M. Mei-Heng and T.W. Sadler, Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro, The FASEB Journal 16 (2002), 619-621.
26. M. Watanabe, J. Osada, Y. Aratani, K. Kluckman, R. Reddick, M.R. Malinow and N. Maeda, Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia, Proc Natl Acad Sci USA 92(5) (1995), 1585-1589.
27. S.H. Mudd, H.L. Levy and F. Skovby, Disorders of transsulfuration, in: The Metabolic and Molecular Bases of Inherited Disease, C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valle, eds, 7 edn. McGraw-Hill, Inc., 1995, pp. 1279-1327.
28. F. Loehrer, C. Angst, W. Haefeli et al., Low whole-blood S- adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease, Arterioscler Thromb Vasc Biol 16 (1996), 227-233.
29. J.B. Schulz, J. Lindenau, J. Seyfried and J. Dichgans, Glutathione, oxidative stress and neurodegeneration, Eur J Biochem 267 (2000), 4904-4911.
30. A. Larsson, S. Orrenius, A. Holmgren and B. Mannervik, Functions of glutathione. Biochemical physiological toxicological and clinical aspects, Raven Press, New York, 1983, 1427-1434.
31. I. Ceballos-Picot, V. Witko-Sarsat, M. Merad-Boudia, A.T. Nguyen, M. Thevenin, M.C. Jaudon, J. Zingraff, C. Verger, P. Jungers and B. Descamps-Latscha, Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure, Free Radic Biol Med 21(6) (1996), 845-853.
32. T.B. Shea, E. Rogers, D. Ortiz and M.-S. Sheu, Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue, Free Rad Biol Med 33 (2002), 1115-1120.
33. Y. Gilgun-Sherki, E. Melamed and D. Offen, Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier, Neuropharmacology 40(8) (2001), 959-975.
34. C. Ramassamy, D. Averill, U. Beffert, S. Bastianetto, L. Theroux, S. Lussier-Cacan, J.S. Cohn, Y. Christen, J. Davignon, R. Quirion and J. Poirier, Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype, Free Radical Biology and Medicine 27 (1999), 5-6, 544-553.
35. G.S. Huang, S.M. Yang, M.Y. Hong, P.C. Yang and Y.C. Liu, Differential gene expression of livers from ApoE-deficient mice, Life Sci 68 (2000), 19-28.
36. T.B. Shea and E. Rogers, Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: augmentation by vitamin E, Mol Brain Res 108 (2002), 1-6.
37. F. Tchantchou, M. Graves, D. Ashline, A. Moran, A. Pimenta, T.B. Shea, Increased transcription and D. Ortiz, E. Rogers and activity of Glutathione synthase in response to deficiencies to deficiencies in Folate, vitamin E and apolipoprotein E, J Neurosci Res 75 (2004), 508-515.
38. M.A. Lovell, C. Xie and W.R. Markesbery, Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease, Neurology 51 (1998), 1562-1566.
39. M.Y. Aksenov, H.M. Tucker, P. Nair, M.V. Aksenova, D.A. Butterfield, S. Estus and W.R. Markesbery, The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease, J Mol Neurosci 11 (1998), 151-164.